Zúñiga-Hernandez Jessica, Quiñones San Martin Matías, Figueroa Benjamín, Novoa Ulises, Monsalve Francisco A, Bacho Mitchell, San-Martin Aurelio, González Daniel R
Department of Basic Biomedical Sciences, Faculty of Health Sciences, Universidad de Talca, Talca 3460000, Chile.
Doctorado en Ciencias, Mención I+D de Productos Bioactivos, Instituto de Química de Recursos Naturales, Universidad de Talca, Talca 3341717, Chile.
Pharmaceuticals (Basel). 2024 Jun 6;17(6):746. doi: 10.3390/ph17060746.
() is a shrub of the Andean Altiplano of Bolivia, Chile and Peru, consumed by local communities as a traditional medicine for several maladies such as diabetes, hepatic and inflammatory diseases. is rich in mulinane- and azorellane-type diterpenoids. For two of these, acute hypoglycemic effects have been described, but the impact of diterpenoids on fatty liver disease has not been investigated. Therefore, organic fractions were prepared using petroleum ether, dichloromethane and methanol. Their content was characterized by UHPLC/MS, revealing the presence of ten diterpenoids, mainly mulinic acid, azorellanol and mulin-11,13-diene. Next, mice fed with a high-fat diet (HFD), a model of metabolic dysfunction-associated fatty liver disease (MAFLD), received one of the fractions in drinking water for two weeks. After this treatment, hepatic parameters were evaluated. The fractions did not reduce hyperglycemia or body weight in the HFD-fed mice but increased the serum levels of hepatic transaminases (AST and ALT), reduced albumin and increased bilirubin, indicating hepatic damage, while histopathological alterations such as steatosis, inflammation and necrosis generated by the HFD were, overall, not ameliorated by the fractions. These results suggest that organic extracts may generate hepatic complications in patients with MAFLD.
(某植物)是一种生长在玻利维亚、智利和秘鲁安第斯高原的灌木,当地社区将其作为治疗糖尿病、肝脏疾病和炎症性疾病等多种疾病的传统药物。它富含穆里烷型和氮杂瑞香烷型二萜类化合物。其中两种二萜类化合物已被描述具有急性降血糖作用,但二萜类化合物对脂肪肝疾病的影响尚未得到研究。因此,使用石油醚、二氯甲烷和甲醇制备了该植物的有机提取物。通过超高效液相色谱/质谱联用技术对其成分进行了表征,结果显示存在十种二萜类化合物,主要是穆里酸、氮杂瑞香醇和穆里-11,13-二烯。接下来,给喂食高脂饮食(HFD)的小鼠(一种代谢功能障碍相关脂肪性肝病(MAFLD)模型)饮用含有其中一种提取物的水,持续两周。经过这种处理后,评估肝脏参数。这些提取物并未降低喂食HFD小鼠的血糖或体重,但却增加了血清肝转氨酶(AST和ALT)水平,降低了白蛋白水平并增加了胆红素水平,表明存在肝损伤,而HFD引起的诸如脂肪变性、炎症和坏死等组织病理学改变总体上并未因这些提取物而得到改善。这些结果表明,该植物的有机提取物可能会在MAFLD患者中引发肝脏并发症。